|
2024-11-18 |
2024-11-14 |
S
Sale
|
BIOTECH TARGET N V
Large shareholder
|
1,279,820
-100.0%
0.66
USD 845,833
|
1,279,820
-100.0%
|
0.66
|
USD 845,833
|
|
|
2024-04-04 |
2024-04-02 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
250,000
+24.3%
2.35
USD 587,500
|
250,000
+24.3%
|
2.35
|
USD 587,500
|
|
|
2023-07-19 |
2023-07-17 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
4,255,319
+38.0%
0.47
USD 2,000,000
|
4,255,319
+38.0%
|
0.47
|
USD 2,000,000
|
|
|
2022-06-21 |
2022-06-16 |
B
Purchase
|
McLennan Sean
See remarks
Officer
|
30,000
+inf%
0.82
USD 24,477
|
30,000
+inf%
|
0.82
|
USD 24,477
|
|
|
2022-06-21 |
2022-06-15 |
B
Purchase
|
SHV Management Services, LLC
Large shareholder
|
62,000
+38.8%
0.89
USD 55,180
|
62,000
+38.8%
|
0.89
|
USD 55,180
|
|
|
2022-06-21 |
2022-06-15 |
B
Purchase
|
LALANDE KEVIN M.
Non-Executive Director
Large shareholder
|
62,000
+38.8%
0.89
USD 55,180
|
62,000
+38.8%
|
0.89
|
USD 55,180
|
|
|
2022-06-21 |
2022-06-14 |
B
Purchase
|
SHV Management Services, LLC
Large shareholder
|
60,000
+60.0%
0.87
USD 52,200
|
60,000
+60.0%
|
0.87
|
USD 52,200
|
|
|
2022-06-21 |
2022-06-14 |
B
Purchase
|
LALANDE KEVIN M.
Non-Executive Director
Large shareholder
|
60,000
+60.0%
0.87
USD 52,200
|
60,000
+60.0%
|
0.87
|
USD 52,200
|
|
|
2022-06-21 |
2022-06-13 |
B
Purchase
|
SHV Management Services, LLC
Large shareholder
|
100,000
+inf%
0.91
USD 91,000
|
100,000
+inf%
|
0.91
|
USD 91,000
|
|
|
2022-06-21 |
2022-06-13 |
B
Purchase
|
LALANDE KEVIN M.
Non-Executive Director
Large shareholder
|
100,000
+inf%
0.91
USD 91,000
|
100,000
+inf%
|
0.91
|
USD 91,000
|
|
|
2022-05-18 |
2022-05-16 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
200,000
+1.8%
1.18
USD 236,200
|
200,000
+1.8%
|
1.18
|
USD 236,200
|
|
|
2022-01-10 |
2022-01-06 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
200,000
+1.9%
4.04
USD 807,180
|
200,000
+1.9%
|
4.04
|
USD 807,180
|
|
|
2021-06-29 |
2021-06-28 |
S
Sale
|
Kim Jason S.
See remarks
Officer
|
2,770
-3.2%
8.36
USD 23,157
|
2,770
-3.2%
|
8.36
|
USD 23,157
|
|
|
2021-04-21 |
2021-04-19 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
40,852
+0.4%
8.08
USD 329,941
|
40,852
+0.4%
|
8.08
|
USD 329,941
|
|
|
2021-04-19 |
2021-04-15 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
150,000
+1.6%
8.62
USD 1,292,655
|
150,000
+1.6%
|
8.62
|
USD 1,292,655
|
|
|
2021-04-13 |
2021-04-12 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
50,000
+0.6%
8.02
USD 400,830
|
50,000
+0.6%
|
8.02
|
USD 400,830
|
|
|
2021-04-13 |
2021-04-09 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
235,664
+2.7%
8.23
USD 1,939,633
|
235,664
+2.7%
|
8.23
|
USD 1,939,633
|
|
|
2021-04-07 |
2021-04-05 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
200,000
+2.5%
9.44
USD 1,887,100
|
200,000
+2.5%
|
9.44
|
USD 1,887,100
|
|
|
2021-02-25 |
2021-02-24 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
75,000
+0.9%
11.48
USD 860,835
|
75,000
+0.9%
|
11.48
|
USD 860,835
|
|
|
2021-02-25 |
2021-02-23 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
235,004
+3.0%
11.29
USD 2,653,031
|
235,004
+3.0%
|
11.29
|
USD 2,653,031
|
|
